Мировой рынок механических клапанов сердца для детей – тенденции отрасли и прогноз до 2030 года

 Анализ и размер рынка механических клапанов сердца для детей

Растущая распространенность заболеваний клапанов сердца, регулирующие разрешения на новые и усовершенствованные протезы клапанов сердца, растущая осведомленность о заболеваниях клапанов сердца, растущий благоприятный сценарий возмещения расходов на протезы клапанов сердца и доступность разнообразного спектра систем клапанов сердца на рынке являются одними из основных факторов, движущих рынок механических клапанов сердца для детей. Кроме того, технологические достижения и модернизация в секторе здравоохранения создадут новые возможности для рынка механических клапанов сердца для детей в период с 2023 по 2030 год.

По данным анализа Data Bridge Market Research, рынок механических клапанов сердца для детей, объем которого в 2022 году составил 10,3 млрд долларов США, к 2030 году, как ожидается, достигнет 27,38 млрд долларов США при среднегодовом темпе роста 13% в прогнозируемый период с 2023 по 2030 год. Помимо информации о рыночных сценариях, таких как рыночная стоимость, темпы роста, сегментация, географический охват и основные игроки, рыночные отчеты, подготовленные Data Bridge Market Research, также включают в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ конвейера, анализ цен и нормативную базу.

Объем и сегментация рынка механических клапанов сердца для детей      

Определение рынка

Heart valves are required to keep blood flowing in the right direction throughout the body. The heart valves are in charge of maintaining blood pressure and ensuring constant blood flow. When they don't work properly, they cut off the heart, resulting in stenosis. Heart disease encompasses a wide range of conditions that have a significant impact on the heart. As the number of patients suffering from cardiovascular diseases has increased in the last ten years, so has the regulation of heart valves.

Pediatric Mechanical Heart Valve Market Dynamics

Drivers

• Rising usage of Heart valves

Heart valves are required to keep blood flowing in the right direction throughout the body. The heart valves are in charge of maintaining blood pressure and ensuring constant blood flow. When they don't work properly, they cut off the heart, resulting in stenosis. Heart disease encompasses a wide range of conditions that have a significant impact on the heart. As the number of patients suffering from cardiovascular diseases has increased in the last ten years, so has the regulation of heart valves. Factors such as unstable lifestyles, lifestyle diseases, increasing smoking population, ageing population, increasing quality of healthcare, and rapid development of healthcare reimbursement drive market growth during the forecast period.

• Rising number of various heart diseases

Heart attacks and strokes are usually sudden events caused by a blockage in blood flow to the heart or brain. Heart disease and stroke deaths increased by 5.8% and 6.8%, respectively, during the first year of the COVID-19 pandemic. However, the age-related increases in heart disease and stroke were 1.6% and 1.7%, respectively. The most common cause is fatty deposit build-up in the lining of blood vessels that supply the heart or brain. A stroke can be caused by bleeding or blood clots in a brain blood vessel. This trend suggests that the prevalence of cardiovascular disease may rise steeply as the population grows and ages. Moreover, the rising number of heart diseases is expected to act as a driver for the pediatric mechanical heart valve market.

Opportunities

• Increasing awareness of prosthetic devices

A prosthesis is a device designed to replace or improve the function of a missing body part. Prosthetic heart valves are increasingly being used in cases where natural valve abnormalities necessitate intervention. Mechanical heart valves, biological valves, and allogeneic grafts are the three types. The goal of artificial valves is to function hemodynamically similarly to natural valves while causing as few side effects as possible. Cardiovascular prostheses are devices that replace damaged heart tissue. These medical devices are intended to function similarly to normal cardiovascular organs. Artificial hearts enable heart surgeons to treat more heart blocks.

Furthermore, the prevalence of prosthetic valves ranges from 0.2 per 1,000 in people under the age of 18 to 5.3 in people under the age of 18. As a result, rising awareness of prosthetic devices represents a growth opportunity for the market.

Restraints/Challenges

• High cost of transcatheter aortic valve replacement

The rising cost of transcatheter aortic valve replacement (TAVR) procedures, as well as the increasing availability of alternative methods for treating heart valve diseases (HVD), are among the major factors that will obstruct market growth and pose additional challenges to the growth of the paediatric mechanical heart valve market during the forecast period.

This pediatric mechanical heart valve market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pediatric mechanical heart valve market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2020, Boston Scientific Corporation announced that it had begun a controlled launch of the ACURATE neo2TM aortic valve system in Europe. This next-generation transcatheter aortic valve implantation (TAVI) technology is a new platform with multiple features designed to improve the clinical performance of the original ACURATE new platform.

Global Pediatric Mechanical Heart Valve Market Scope

The pediatric mechanical heart valve market is segmented on the basis of population, end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Population

• Infants
• Toddlers
• School Age
• Adolescents

 End-Use

• Hospitals
• Special Clinics
• Ambulatory Surgical Units

Pediatric Mechanical Heart Valve Market Regional Analysis/Insights

The pediatric mechanical heart valve market is and analyzed and market size insights and trends are provided by country, population, end-use as referenced above.

The countries covered in the pediatric mechanical heart valve market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the pediatric mechanical heart valve market because of increased awareness of heart valve diseases and a more favourable reimbursement scenario for prosthetic heart valves in this region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to rise in availability of heart valve disease related surgery devices.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The pediatric mechanical heart valve market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for pediatric mechanical heart valve market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the pediatric mechanical heart valve market. The data is available for historic period 2011-2021.

Competitive Landscape and Pediatric Mechanical Heart Valve Market Share Analysis

The pediatric mechanical heart valve market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pediatric mechanical heart valve market.

Some of the major players operating in the pediatric mechanical heart valve market are:

• Medtronic (Ireland)
• LivaNova PLC (U.K.)
• Abbott (U.S.)
• Colibri Heart Valve (U.S.)
• On-X Life Technologies Inc. (США)
• ТТК (Индия)
• JenaValve Technology Inc. (США)
• CryoLife Inc (США)
• Бостонская научная корпорация (США)
• Корпорация Edwards Lifesciences (США)
• Симетис (Швейцария)
• Lepu Medical Technology (Beijing) Co.Ltd. (Китай)
• Braile Biomédica (Бразилия)
• Micro Interventional Devices, Incorporated (США)
• Auto Tissue Berlin GmbH (Германия)

SKU-56968